| RS1269943135 |
SKIC3
|
Health Risk |
Pathogenic |
Trichohepatoenteric syndrome 1, Trichohepatoenteric syndrome 1 |
| RS1269948810 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1269951927 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1269957639 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1269970394 |
PALB2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1269970737 |
LARS2
|
Health Risk |
Pathogenic |
Perrault syndrome 4, Perrault syndrome 4 |
| RS1269984067 |
ALG6
|
Health Risk |
Pathogenic/Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1269999933 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1270003368 |
HYDIN
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS1270005492 |
PDE6A
|
Health Risk |
Pathogenic |
— |
| RS1270017793 |
KIZ
|
Health Risk |
Likely pathogenic |
— |
| RS1270039330 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1270039585 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS12700428 |
IGF2BP3
|
Health Risk |
association |
Vascular endothelial growth factor (VEGF) inhibitor response, Vascular endothelial growth factor (VEGF) inhibitor response |
| RS1270048702 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1270099780 |
LRP5
|
Health Risk |
Likely pathogenic |
Osteoporosis with pseudoglioma, Osteoporosis with pseudoglioma |
| RS1270151043 |
OAT
|
Health Risk |
Pathogenic |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS1270166239 |
APC
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 1, Familial adenomatous polyposis 1 |
| RS1270172263 |
TERT
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1270184350 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1270186626 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1270198704 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1270212178 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1270242791 |
LZTR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1270264665 |
NSD1
|
Health Risk |
Pathogenic |
— |
| RS1270271346 |
MBD4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Tumor predisposition syndrome 2 |
| RS1270276368 |
ALG1
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, Congenital disorder of glycosylation |
| RS1270283587 |
PKP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 9, Left ventricular noncompaction cardiomyopathy |
| RS1270288366 |
PHIP
|
Health Risk |
Likely pathogenic |
PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome, PHIP-related behavioral problems-intellectual disability-obesity-dysmorphic features syndrome |
| RS1270302810 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, MYO15A-related disorder |
| RS1270309511 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS1270312556 |
SLC6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy with myoclonic atonic seizures, Epilepsy with myoclonic atonic seizures |
| RS1270315601 |
CHD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy 94, Inborn genetic diseases |
| RS1270324533 |
C5
|
Health Risk |
Likely pathogenic |
— |
| RS1270337982 |
ALG6
|
Health Risk |
Likely pathogenic |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1270349297 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1270359418 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1270367757 |
FANCM
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1270369106 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 6, McKusick-Kaufman syndrome |
| RS1270386176 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1270395120 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1270399063 |
TNPO3
|
Health Risk |
Likely pathogenic |
Autosomal dominant limb-girdle muscular dystrophy type 1F, Autosomal dominant limb-girdle muscular dystrophy type 1F |
| RS1270399331 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS1270412613 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS1270417244 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1270417432 |
DST
|
Health Risk |
Pathogenic |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS1270423610 |
ALDH7A1
|
Health Risk |
Pathogenic |
Pyridoxine-dependent epilepsy, See cases |
| RS1270440540 |
ALG6
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG6-congenital disorder of glycosylation 1C, ALG6-congenital disorder of glycosylation 1C |
| RS1270441968 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1270472063 |
ALMS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Alstrom syndrome |
| RS1270472738 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 71 |
| RS1270496059 |
PRDM16
|
Health Risk |
Conflicting classifications of pathogenicity |
Left ventricular noncompaction 8, Left ventricular noncompaction 8 |
| RS1270518681 |
GJB1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease X-linked dominant 1, Charcot-Marie-Tooth disease X-linked dominant 1 |
| RS1270523244 |
PHKG2
|
Health Risk |
Pathogenic |
Glycogen storage disease IXc, Glycogen storage disease type IXc |
| RS1270531724 |
SETD5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1270538282 |
EMC1
|
Health Risk |
Pathogenic |
— |
| RS1270552356 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast cancer, susceptibility to |
| RS1270564492 |
NAGLU
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-B |
| RS1270593506 |
FANCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group B |
| RS1270595568 |
CTC1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, Dyskeratosis congenita |
| RS1270628305 |
NAA15
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 50 |
| RS1270636463 |
FREM2
|
Health Risk |
Pathogenic |
— |
| RS1270654737 |
AHI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Joubert syndrome 3 |
| RS1270674587 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1270675463 |
TIMP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1270702085 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Hereditary cancer-predisposing syndrome |
| RS1270704258 |
CLDN16
|
Health Risk |
Likely pathogenic |
— |
| RS1270729721 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1270730854 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1270740001 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1270747182 |
ALDOB
|
Health Risk |
Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS1270749718 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1270752951 |
SPRED1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Legius syndrome |
| RS1270766408 |
EHMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS1270775688 |
FMO3
|
Health Risk |
Pathogenic/Likely pathogenic |
Trimethylaminuria, Trimethylaminuria |
| RS1270783041 |
APC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Gastric cancer |
| RS1270810159 |
HBA2
|
Health Risk |
Pathogenic/Likely pathogenic |
alpha Thalassemia, Heinz body anemia |
| RS1270853129 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1270857666 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1270867914 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1270869520 |
SBF2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS1270887856 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1270892737 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Gorlin syndrome |
| RS1270894276 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS1270910813 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1270911408 |
OTOG
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1270916321 |
DNAH5
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 3 |
| RS1270971513 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS1270977202 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa |
| RS1270986936 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1271000541 |
MITF
|
Health Risk |
Conflicting classifications of pathogenicity |
Waardenburg syndrome type 2A, MITF-related disorder |
| RS1271011315 |
DBT
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1271018624 |
RUNX2
|
Health Risk |
Pathogenic |
— |
| RS1271025077 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS12710260 |
LDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS1271031981 |
LAMP2
|
Health Risk |
Pathogenic |
Danon disease, Danon disease |
| RS1271040251 |
NAA15
|
Health Risk |
Pathogenic |
— |
| RS1271064370 |
CLN5
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS1271065895 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1271107737 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |